A 24 Month, multi-center, open-lable randomized, controlled study to evaluate the efficacy and safety of concentration-controlled everolimus to eliminate or reduce racrolimus compared to tacrolimus in de novo liver transplant recipients.
|Effective start/end date||7/2/09 → 1/4/12|
- Novartis Pharma AG
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.